Fatty acid composition of serum and tissue lipids in benign and malignant gynecologic disease.
D000230:Adenocarcinoma / Q000097:blood / Q000378:metabolism; D002277:Carcinoma / Q000097:blood / Q000378:metabolism; D002584:Cervix Uteri / Q000032:analysis; D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D004717:Endometrium / Q000032:analysis; D005227:Fatty Acids / Q000032:analysis* / Q000097:blood*; D005260:Female; D005831:Genital Diseases, Female / Q000378:metabolism*; D005833:Genital Neoplasms, Female / Q000378:metabolism*; D006801:Humans; D007889:Leiomyoma / Q000097:blood / Q000378:metabolism; D010048:Ovarian Cysts / Q000097:blood / Q000378:metabolism; D010051:Ovarian Neoplasms / Q000097:blood / Q000378:metabolism; D010053:Ovary / Q000032:analysis; D010743:Phospholipids / Q000032:analysis; D002583:Uterine Cervical Neoplasms / Q000097:blood / Q000378:metabolism; D002575:Uterine Cervicitis / Q000378:metabolism; D014594:Uterine Neoplasms / Q000097:blood / Q000378:metabolism; D014599:Uterus / Q000032:analysis
D005227:Fatty Acids; D010743:Phospholipids